<DOC>
	<DOC>NCT01033864</DOC>
	<brief_summary>This open-label, 2-arm study will compare the pharmacokinetics of CellCept and mycophenolate sodium in kidney transplanted patients on a calcineurininhibitor-free mycophenolic acid-based therapy. On the study day patients will take their prescribed medication (either CellCept or mycophenolate sodium). Blood samples will be drawn directly before and at intervals up to 12 hours after intake of the study medication. Anticipated time on study treatment is 12 hours and target sample size is 24.</brief_summary>
	<brief_title>A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>adult patients, &gt;/=18 years of age kidney transplantation &gt;/=6 months ago on mycophenolic acidbased, calcineurininhibitorfree therapy for &gt;/=3 months, &gt;/=1 month on stable dose cotherapy with 5mg prednisone for &gt;/=1 month active gastrointestinal ulcus severe diarrhea od gastrointestinal disease severe impairment of renal function current malignancy LeschNyhan or KelleySeegmillerSyndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>